Resection post-radio-embolization in patients with single large hepatocellular carcinoma  

作　　者：Kevin Hakkakian Nicolas Golse 

机构地区：[1]Centre Hépato-Biliaire,Hôpital Paul-Brousse,Assistance Publique Hôpitaux de Paris,Villejuif,France [2]UniversitéParis-Saclay,UMRS 1193,Physiopathogénèse et Traitement des Maladies du Foie,FHU Hepatinov,Villejuif,France

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第2期307-310,共4页肝胆外科与营养（英文）

摘　　要：We read with interest this article evaluating the results of transarterial radioembolization(TARE)in the management of large(≥5 cm)initially unresectable hepatocellular carcinoma(HCC)(1).The aim of this retrospective study was to compare the results of upfront resection(single,resectable large HCC)with resection preceded by TARE(single,initially unresectable large HCC).The authors retrospectively analyzed the 216 patients managed with a single HCC larger than 5 cm,between 2015 and 2020 in their center.Patients were divided into two groups:upfront surgery(n=144,66.7%)or TARE if considered unresectable(n=72,33.3%).Then,among those who had undergone TARE,a further dichotomy was made between those who had undergone surgery(“TARE-surgery”,n=20,9%)and those who had not(“TARE-only”,n=52,24%).

关 键 词：Surgery hepatocellular carcinoma(HCC) transarterial radioembolization(TARE) DOWNSTAGING radio-embolization 

分 类 号：R735.7[医药卫生—肿瘤]